Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
PO-34 - Optimal doses of tinzaparin to reduce both cancer-associated thrombosis and tumor growth in a mouse model of ectopic pancreatic syngeneic tumor
Home
Publications
PO-34 - Optimal doses of tinzaparin to reduce both cancer-associated thrombosis and tumor growth in a mouse model of ectopic pancreatic syngeneic tumor
PO-34 - Optimal doses of tinzaparin to reduce both cancer-associated thrombosis and tumor growth in a mouse model of ectopic pancreatic syngeneic tumor
Authors:
LP
L. Panicot-Dubois
L. Panicot-Dubois
SM
S. Mezouar
S. Mezouar
LP
L. Plantureux
L. Plantureux
LC
L. Crescence
L. Crescence
CF
C. Frère
C. Frère
C. Dubois
C. Dubois
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Publisher website
Google Scholar
1 April 2016
journal article
Published by
Elsevier
in
Thrombosis Research
Vol. 140
,
S189
DOI:
10.1016/s0049-3848(16)30167-0
PMID:
27161722
Abstract
No abstract available
Keywords
HEPARINS
PANCREATIC
TINZAPARIN
THROMBOSIS
MICE
CANCER
OPTIMAL DOSES
KINETICS
THROMBUS
Cited
Cited by 3 articles
Scroll to top